Parkinson’s disease (PD) should be given priority to get the coronavirus vaccines because they are at a high risk of developing severe illness from COVID-19, some experts say.In an article published in the Journal of Parkinson’s Disease on Wednesday, scientists and medical professionals said that the approved mRNA-based vaccines from Pfizer-BioNTech and Moderna are not known to interact with the brain degeneration caused by PD. ‘World first’ Parkinson’s treatment undergoing clinical trial in Toronto There is also no evidence that the COVID-19 vaccines could interfere with the current therapies of Parkinson’s, the authors noted.“This is really a high-risk group that deserves to be vaccinated quickly,” Bastiaan R.